Mesenchymal Stem Cells (Covalon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMesenchymal Stem Cells (Covalon)
Drug Alias NameMesenchymal Stem Cells (Covalon)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionEndothelial PAS domain-containing protein 1 stimulants
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/IndicationsIschemiaMyocardial InfarctionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCovalon Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCovalon Technologies Inc
Active IndicationsN/A
Inactive IndicationsIschemiaMyocardial InfarctionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A